XML 105 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the six months ended June 30, 2021:
 
Expected term (in years)5.91
Expected volatility58.6 %
Risk-free interest rate0.9 %
Expected dividend yield— %
Share-based Payment Arrangement, Option, Activity
Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years):
 
SharesWeighted
Average
Exercise
Price		Weighted
Average
Contractual
Period
(in Years)		Aggregate
Intrinsic
Value
Outstanding at December 31, 202026,459 $1.16 8.50$131,770 
Recapitalization(14,474)1.41 
Outstanding at December 31, 202011,985 2.57 8.50131,770 
Granted1,014 13.77 
Exercised (including early exercised options vested during the period)(811)0.77 
Forfeited and expired(156)2.51 
Outstanding at June 30, 202112,032 3.63 8.2190,246 
Vested and expected to vest as of June 30, 202112,032 3.63 8.2190,246 
Exercisable as of June 30, 202110,798 $2.75 8.07$88,157 
Share-based Payment Arrangement, Option, Exercise Price Range
The options outstanding and exercisable as of June 30, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in thousands, except weighted average remaining contractual life and exercise price):
 
 Options OutstandingOptions Exercisable
Exercise PriceSharesWeighted Average Remaining Contractual Life 
(in Years)		SharesWeighted Average Remaining Contractual Life 
(in Years)
$ 0.06 – 0.40
2,919 6.562,885 6.56
1.55 – 2.33
3,201 7.873,042 7.87
2.43 – 3.65
3,270 8.913,269 8.91
8.90 – 13.35
1,924 9.461,569 9.42
13.90 – 20.85
718 9.8233 9.73
12,032 10,798 
Schedule of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:
Expected term0.16
Volatility65.0 %
Risk-free rate— %
Dividend yield— %
The following assumptions were used in this valuation:
Expected term (in years)5.00
Expected volatility60.0 %
Risk-free interest rate0.5 %
Expected dividend yield— %
Share-based Payment Arrangement, Restricted Stock Unit, Activity
RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):

SharesWeighted Average Grant Date Fair Value
Unvested at December 31, 20203,480 $5.30 
Recapitalization(1,904)5.99 
Unvested at December 31, 20201,576 11.29 
Granted3,535 13.32 
Vested(1,137)12.94 
Forfeited and expired(29)13.38 
Unvested at June 30, 20213,945 $12.59 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2021 and June 30, 2020 (in thousands):
 
Three Months Ended
June 30,		Six Months Ended
June 30,
2021202020212020
Marketing$772 $367 $2,618 $658 
Selling, general, and administrative8,388 1,558 40,772 2,671 
Total stock-based compensation expense$9,160 $1,925 $43,390 $3,329 
Share-based Payment Arrangement, Activity
Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years):

SharesWeighted Average Exercise PriceWeighted Average Contractual Term (in Years)Aggregate Intrinsic Value
Outstanding at December 31, 20201,861 $0.79 7.01$9,957 
Recapitalization(1,018)0.96 
Outstanding at December 31, 2020843 1.75 7.019,957 
Exercised(381)1.75 
Outstanding at June 30, 2021462 1.75 7.014,226 
Vested and expected to vest as of June 30, 2021462 1.75 7.014,226 
Exercisable as of June 30, 2021324 $1.75 7.01$2,958